Circulating and tumor‐infiltrating myeloid cells predict survival in human pleural mesothelioma

Malignant pleural mesothelioma (MPM) tumor cells produce copious amounts of myeloid cell‐stimulating factors. The current study examined the prognostic significance of circulating monocytes and tumor‐infiltrating macrophages on overall survival in patients with MPM.

[1]  R. White.  Pancreatic neuroendocrine tumors: selection, selection, selection…. , 2011, The Journal of surgical research.

[2]  S. Natsugoe,et al.  Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. , 2011, The Journal of surgical research.

[3]  P. Allavena,et al.  Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation , 2009, Journal of leukocyte biology.

[4]  L. Coussens,et al.  CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. , 2009, Cancer cell.

[5]  M. Hebbar,et al.  Interferon‐γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor‐associated macrophages , 2009, International journal of cancer.

[6]  H. Møller,et al.  Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Ming-Huang Chen,et al.  Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer , 2009, Journal of Cancer Research and Clinical Oncology.

[8]  S. Asgharzadeh,et al.  Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. , 2009, The Journal of clinical investigation.

[9]  S. Mocellin,et al.  IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1 , 2009, The Journal of Immunology.

[10]  F. Geissmann,et al.  Blood monocytes: development, heterogeneity, and relationship with dendritic cells. , 2009, Annual review of immunology.

[11]  C. Mullany,et al.  Survival After Resection of Primary Cardiac Tumors: A 48-Year Experience , 2008, Circulation.

[12]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[13]  T. Lawrence,et al.  “Re-educating” tumor-associated macrophages by targeting NF-κB , 2008, The Journal of experimental medicine.

[14]  P. Allavena,et al.  The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance , 2008, Immunological reviews.

[15]  M. Tsao,et al.  Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. , 2008, The Journal of thoracic and cardiovascular surgery.

[16]  D. Morton,et al.  Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients , 2007, Journal of immunotherapy.

[17]  D. McMillan,et al.  Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer , 2007, British Journal of Cancer.

[18]  Stephan Gripp,et al.  Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Sica,et al.  Altered macrophage differentiation and immune dysfunction in tumor development. , 2007, The Journal of clinical investigation.

[20]  S. Kitano,et al.  Prognostic Value of Preoperative Peripheral Blood Monocyte Count in Patients with Colorectal Liver Metastasis after Liver Resection , 2007, Journal of Gastrointestinal Surgery.

[21]  Paolo Serafini,et al.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.

[22]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[23]  A. Issekutz,et al.  Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation , 2006, Journal of leukocyte biology.

[24]  H. Pass,et al.  TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis , 2006, Proceedings of the National Academy of Sciences.

[25]  H. Hammad,et al.  Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses , 2006, European Respiratory Journal.

[26]  Gefeng Zhu,et al.  B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma , 2006, The Journal of experimental medicine.

[27]  M. Carbone,et al.  The pathogenesis of mesothelioma. , 2006, Seminars in diagnostic pathology.

[28]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[29]  N. Marcussen,et al.  Monocytes and neutrophils as ‘bad guys’ for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trial , 2006, British Journal of Cancer.

[30]  Z. Trajanoski,et al.  Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.

[31]  K. O'Byrne,et al.  Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  B. Robinson,et al.  Advances in malignant mesothelioma. , 2005, The New England journal of medicine.

[33]  J. Gehl,et al.  Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model , 2005, British Journal of Cancer.

[34]  David J Sugarbaker,et al.  Tumorigenesis and Neoplastic Progression Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling , 2005 .

[35]  S. Signoretti,et al.  Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. , 2005, Cancer research.

[36]  G. Trinchieri,et al.  Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. , 2005, Cancer research.

[37]  C. June,et al.  Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma , 2005, Cancer biology & therapy.

[38]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[39]  Claude Denham,et al.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .

[41]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[42]  J. Miller,et al.  Survival after conservative (palliative) management of pleural malignant mesothelioma , 2001, Journal of surgical oncology.

[43]  P. Rutkowski,et al.  Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  J. Herndon,et al.  Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. , 1998, Chest.

[45]  T. Lee,et al.  Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. , 1993, Journal of immunology.

[46]  R. Stahel,et al.  Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: Interleukin‐6 production as a common feature , 1992, International journal of cancer.

[47]  G. Demetri,et al.  Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. , 1989, Blood.

[48]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[49]  I. Webster,et al.  Lymphocytic infiltration of pleural mesothelioma and its significance for survival. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[50]  E. Livstone,et al.  Absolute granulocyte, lymphocyte, and moncyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. , 1982, JAMA.

[51]  C. Loddenkemper,et al.  Impaired immune functions of monocytes and macrophages in Whipple's disease. , 2010, Gastroenterology.

[52]  C. Palumbo,et al.  Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophages. , 2009, International journal of oncology.

[53]  W. Richards,et al.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.